Research in Ristimäki Lab focuses on the molecular background of gastrointestinal tumors, mainly colorectal cancer and appendix-originating pseudomyxoma peritonei. In addition to understanding the molecular aberrations behind gastrointestinal tumorigenesis, our ultimate goal is to identify novel diagnostic biomarkers and therapy targets. Besides gene and protein level changes, we also study changes concerning cellular glycosylation.